Circulating Tumor DNA (ctDNA) Sequencing
A New Generation of Cancer Biomarkers – Circulating Tumor DNA (ctDNA) Detection and Monitoring
Circulating tumor DNA (ctDNA) are fragments of DNA from dying cancer cells found in the blood of cancer patients. At Ayass BioScience, we utilize a minimally invasive method (alternative to risky and invasive tumor biopsies) that requires only a few milliliters of plasma from patients to detect mutations in genes associated with cancer. ctDNA is detectable for most types of cancer and could be used as an effective screening method and as a way to monitor the response to therapeutic treatments for most patients.
ctDNA
NEXT GENERATION SEQUENCING – SOMATIC MUTATION
Our ctDNA panel targets 28 genes commonly found mutated in solid tumor type cancers. This assay is performed using cell free DNA isolated from human plasma specimens. The test is intended to identify the presence of circulating tumor DNA and identify mutations in genes associated with cancer. The test can be used for the monitoring of cancer remission after treatment such as chemotherapy, radiation or surgery.
If you have any questions about Circulating Tumor DNA Sequencing at Ayass BioScience, LLC, please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.
